Inhalation administration in form of e.g. hypertonic solutions, useful for the removal of bronchial secretions, comprises an osmolar-acting agent e.g. sodium chloride, and hyaluronic acid, suspect preservatives or pharmaceutical excipients

摘要

Inhalation administration in the form of hypertonic solutions or dry powders, comprises an osmolar-acting agent of either sodium chloride or mannitol, and hyaluronic acid of biotechnical origin with low molecular weight, or its salt, suspect preservatives or pharmaceutical excipients.